SHARON GREENBERG: Open Payments
NPI 1033432968 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,108 in 59 payments from 21 companies in 2025. Trend: 2023 $961 · 2024 $995 · 2025 $1,108
Food & beverage: $1,108
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $244 |
| Novo Nordisk Inc | 8 | $180 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $82 |
| Lilly USA, LLC | 4 | $79 |
| Amgen Inc. | 4 | $66 |
| AstraZeneca Pharmaceuticals LP | 3 | $54 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $52 |
| Astellas Pharma US Inc | 2 | $51 |
| Novartis Pharmaceuticals Corporation | 2 | $33 |
| Medtronic, Inc. | 1 | $31 |
Products named: QULIPTA, Wegovy, CAPLYTA, MOUNJARO, OTEZLA, AIRSUPRA, JARDIANCE, Veozah.
Industry payments across PA — which companies pay providers there.
